The burgeoning landscape of emerging treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mode agonists targeting the GLP-1 and GIP receptors. While sharing a alike https://aprilvuxs223993.wikibuysell.com/2011390/retatrutide_vs_tirzepatide_a_comparative_analysis